Viracta Therapeutics Cash from Operations (TTM) Insights

Viracta Therapeutics Inc (VIRX)

0.761 -0.04 (-4.85%) USD | NASDAQ | May 22, 16:00

0.761 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	-36.40M
December 31, 2023	-39.89M
September 30, 2023	-37.77M
June 30, 2023	-34.39M
March 31, 2023	-35.43M
December 31, 2022	-35.46M
September 30, 2022	-34.76M

Date	Value
June 30, 2022	-35.21M
March 31, 2022	-32.76M
December 31, 2021	-18.85M
September 30, 2021	-16.18M
June 30, 2021	-12.84M
March 31, 2021	-9.845M
December 31, 2020	-16.05M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-39.89M

Minimum

Dec 2023

-9.845M

Maximum

Mar 2021

-28.27M

Average

-34.58M

Median

Cash from Operations (TTM) Benchmarks